Ferguson / Fennerty | Managing Failed Anti-Reflux Therapy | E-Book | www2.sack.de
E-Book

E-Book, Englisch, 196 Seiten

Ferguson / Fennerty Managing Failed Anti-Reflux Therapy


1. Auflage 2006
ISBN: 978-1-84628-011-5
Verlag: Springer
Format: PDF
Kopierschutz: 1 - PDF Watermark

E-Book, Englisch, 196 Seiten

ISBN: 978-1-84628-011-5
Verlag: Springer
Format: PDF
Kopierschutz: 1 - PDF Watermark



Comprehensive and up-to-date analysis of GERD Has focus on remedies to failed treatment of the disease

Ferguson / Fennerty Managing Failed Anti-Reflux Therapy jetzt bestellen!

Weitere Infos & Material


1;Preface;6
2;Contents;8
3;Contributors;10
4;1 The Epidemiology and Pathophysiology of Gastroesophageal Reflux Disease --- Peter J. Kahrilas and John E. Pandolfino;12
4.1;GERD Pathophysiology;13
4.2;Functional Constituents of the EGJ;13
4.3;Mechanisms of EGJ Incompetence in GERD;16
4.4;Transient LES Relaxations;16
4.5;LES (Intrinsic Sphincter) Hypotension;17
4.6;The Diaphragmatic Sphincter and Hiatus Hernia;18
4.7;Gastroesophageal Flap Valve;18
4.8;Mechanical Properties of the Relaxed EGJ;18
4.9;Esophageal Acid Clearance;20
4.10;Impairments of Esophageal Emptying;21
4.11;Salivary Function;21
4.12;Summary;22
4.13;References;22
5;2 History of Medical and Surgical Anti-Reflux Therapy --- Mark K. Ferguson;26
5.1;Early Nonsurgical Therapy;27
5.2;Esophageal Dilation;27
5.3;Esophageal Stents;28
5.4;Palliative Surgical Therapy;29
5.5;Early Surgical Therapy;30
5.6;Physiologic Surgical Therapy;31
5.7;Pharmacologic Therapy;34
5.8;Endoscopic Therapy;35
5.9;References;36
6;3 Medical Management of GERD: Algorithms and Outcomes --- David A. Johnson;42
6.1;Background;42
6.2;Lifestyle/Diet Modifications;43
6.3;Antacids;43
6.4;Promotility Agents;44
6.5;H2-Receptor Antagonists;45
6.6;Proton Pump Inhibitors;45
6.7;Nocturnal Acid Breakthrough (PPI Plus H2RA);46
6.8;Maintenance of Remission;46
6.9;Barrett’s Esophagus;46
6.10;Extraesophageal GERD;47
6.11;Measuring Esophageal pH As an Outcome of Anti-Reflux Therapy;48
6.12;Measuring Esophageal Motility and LESP As an Outcome of Anti-Reflux Therapy;49
6.13;Endoscopic Assessment Endpoints As an Outcome of Anti-Reflux Therapy;49
6.14;Symptom Assessment As an Outcome of Anti-Reflux Therapy;50
6.15;Quality-of-Life Assessment As an Outcome of Anti-Reflux Therapy;51
6.16;Medication Use As an Outcome of Anti-Reflux Therapy;51
6.17;Conclusions;52
6.18;References;52
7;4 Complications of GERD: Esophagitis, Stricture, Barrett’s, and Cancer --- John A. Bonino and Prateek Sharma;56
7.1;Erosive Esophagitis;56
7.1.1;Prevalence;56
7.1.2;Pathogenesis and Risk Factors;57
7.1.3;Symptoms;58
7.1.4;Treatment;58
7.2;Esophageal (Peptic) Stricture;59
7.2.1;Pathogenesis and Prevalence;59
7.2.2;Risk Factors;59
7.2.3;Symptoms;59
7.2.4;Treatment;59
7.3;Barrett’s Esophagus;60
7.3.1;Prevalence;60
7.3.2;Pathogenesis and Risk Factors;60
7.3.3;Symptoms;61
7.3.4;Surveillance;61
7.3.5;Medical Therapy;62
7.3.6;Anti-reflux Surgery;62
7.3.7;Endoscopic Therapy;62
7.4;Esophageal Adenocarcinoma;63
7.4.1;Incidence;63
7.4.2;Pathogenesis;63
7.4.3;Risk Factors;63
7.4.4;Symptoms;64
7.4.5;Treatment;64
7.5;Summary;64
7.6;References;65
8;5 Principles of Successful Surgical Anti-Reflux Procedures --- Federico Cuenca-Abente, Brant K. Oelschlager, and Carlos A. Pellegrini;68
8.1;Indications;68
8.1.1;Averse to Lifestyle Changes;68
8.1.2;Poor Response to Proton Pump Inhibitors;68
8.1.3;Patients with Airway Manifestations of GERD;69
8.1.4;Patients with Barrett’s Esophagus;69
8.2;Contraindications;69
8.2.1;Morbid Obesity;69
8.2.2;Severe Comorbidities;69
8.3;Preoperative Evaluation;69
8.3.1;Flexible Endoscopy (EGD);69
8.3.2;Manometry;70
8.3.3;Twenty-four-hour pH Esophageal Monitoring;70
8.3.4;Upper Gastrointestinal Series;70
8.3.5;Twenty-four-hour Esophageal and Pharyngeal pH Monitoring;70
8.3.6;Laryngoscopy;70
8.3.7;Impedance;70
8.4;Surgical Technique—Nissen Fundoplication;71
8.4.1;Basic Tenants of Anti-Reflux Procedures;71
8.4.2;Relative Advantages of Different Fundoplications;71
8.4.3;Perioperative Considerations;72
8.4.4;Creation of Pneumoperitoneum and Port Placement;72
8.4.5;Dissection of the Cardia (“Left Crus Approach”);73
8.4.6;Division of the Short Gastric Vessels;73
8.4.7;Esophageal Mobilization;73
8.4.8;Hiatal Closure;74
8.4.9;Construction of the Wrap;74
8.4.10;Anchoring the Fundoplication;74
8.5;Conclusio;75
8.6;References;75
9;6 Acute Complications of Anti-Reflux Surgery --- Gianmattia del Genio and Jean-Marie Collard;78
9.1;Intraoperative Complications;79
9.1.1;Vascular Injury;79
9.1.2;Esophageal and Gastric Tear;80
9.1.3;Vagal Nerve Injury;81
9.1.4;Pneumomediastinum and Pneumothorax;81
9.2;Acute Postoperative Complications;82
9.2.1;Gastric and Esophageal Fistula;82
9.2.2;Bleeding;83
9.2.3;Herniation of the Wrap into the Chest;84
9.2.4;Acute Dysphagia;85
9.3;Summary;86
9.4;References;86
10;7 Persistent Symptoms after Anti-Reflux Surgery and their Management --- John G. Hunter and M. Brian Fennerty;90
10.1;Introduction;90
10.2;Evaluation of Patients with New or Recurrent Symptoms of GERD;90
10.2.1;Early Postoperative Symptoms;90
10.2.2;Recurrent GERD Symptoms;91
10.2.3;Persistent Postoperative Dysphagia;93
10.3;Anatomic Failure of Nissen Fundoplication;95
10.3.1;Fundoplication Herniation;95
10.3.2;Slipped Nissen Fundoplication;95
10.3.3;Disrupted Fundoplication, Twisted Fundoplication, and the Twocompartment Stomach;96
10.3.4;Bloating, Nausea, and Epigastric Pain;96
10.3.5;Reoperation for Fundoplication Failure;98
10.3.6;Exposure for Reoperative Laparoscopic Fundoplication;98
10.4;Conclusion;99
10.5;References;99
11;8 Technical Surgical Failures: Presentation, Etiology, and Evaluation --- Carrie A. Sims and David W. Rattner;102
11.1;Presenting Symptoms of Failed Anti-Reflux Operations;102
11.2;Methods of Evaluation;103
11.3;Potential Causes of Failure;105
11.4;Treatment Options;107
11.4.1;What Is the Best Surgical Approach to a Reoperation?;108
11.4.2;Choosing a Partial or a Total Fundoplication;109
11.4.3;Considerations for Esophageal Lengthening Procedures;109
11.4.4;Management of the Difficult Hiatus;110
11.4.5;Technical Tips for Laparoscopic Reoperations;111
11.5;Conclusion;112
11.6;References;112
12;9 Symptoms after Anti-Reflux Surgery: Everything is not always caused by Surgery --- Kenneth R. DeVault;114
12.1;Dysphagia;114
12.2;Gas Bloat and Upper Abdominal Discomfort;115
12.3;Flatulence, Diarrhea, and Irritable Bowel Syndrome;117
12.4;Recurrent Heartburn;118
12.5;Recurrent “Atypical” Symptoms;119
12.6;Summary;120
12.7;References;120
13;10 The Medical and Endoscopic Management of Failed Surgical Anti-Reflux Procedures --- M. Brian Fennerty and John G. Hunter;124
13.1;Magnitude of the Problem;124
13.2;Documentation of Recurrent Reflux after Surgical Anti-Reflux Therapy;124
13.3;Endoscopic Assessment of a Prior Surgical Anti-Reflux Procedure;126
13.4;Ambulatory Esophageal pH Monitoring in Patients with Prior Anti-Reflux Procedures;128
13.5;Other Tests of Gastrointestinal Physiology and Function;129
13.6;Endoscopic and Pharmacological Therapy after Failed Anti-Reflux Surgery;129
13.6.1;Endoscopic Anti-Reflux Procedures in General;129
13.6.2;Food and Drug Administration Status of Endoscopic Anti-Reflux Procedures;130
13.6.3;Reimbursement Status of Endoscopic Anti-Reflux Procedures;130
13.6.4;Short- and Long-term Outcomes of Endoscopic Anti-Reflux Procedures;130
13.6.5;Use of Endoscopic Anti-Reflux Procedures in This Clinical Situation;131
13.6.6;Pharmacological Therapy for Failed Anti-Reflux Surgery;132
13.6.7;Use in This Clinical Situation;133
13.7;Conclusions;134
13.8;References;134
14;11 Reoperation for Failed Anti-Reflux Surgery --- Jennefer A. Kieran and Myriam J. Curet;138
14.1;Preoperative Evaluation;138
14.2;Operative Techniques;139
14.2.1;Open Laparotomy for Reoperative Fundoplication;139
14.2.2;Laparoscopic Revision of Fundoplication;141
14.2.3;Comparison of Open Versus Laparoscopic Refundoplication;144
14.2.4;Laparoscopic Gastric Bypass for Recurrent Reflux;145
14.2.5;Thoracotomy;146
14.3;Postoperative Management;147
14.4;Summary;147
14.5;References;147
15;12 Management of Alkaline Reflux --- Jose M. Clavero, Philippe Topart, and Claude Deschamps;150
15.1;Pathogenesis;150
15.2;Diagnosis;151
15.2.1;Endoscopy;151
15.2.2;Scintigraphy;151
15.2.3;Aspiration Studies;151
15.2.4;Twenty-four-hour pH Monitoring;152
15.2.5;Bilirubin Monitoring;153
15.3;Treatment;153
15.3.1;Bile Diversion Operations;153
15.3.2;Total Duodenal Diversion;153
15.3.3;Duodenal Switch;155
15.3.4;Biliary Diversion;156
15.4;Technical Aspects;156
15.4.1;Long-limb Roux-Y Jejunal Reconstruction after Total or Proximal Gastrectomy;156
15.5;Conclusion;158
15.6;References;158
16;13 Management of the Short Esophagus --- Éric Fréchette and André Duranceau;162
16.1;Evolution of Hiatal Hernia and Anti-Reflux Surgery;162
16.2;Definition;163
16.3;Etiology;163
16.4;nvestigation;164
16.4.1;Radiology;164
16.4.2;Endoscopy and Esophageal Biopsies;165
16.4.3;Motility Studies;165
16.4.4;Monitoring Acid and Bile Reflux;166
16.5;Medical Management;166
16.6;Surgical Treatment;166
16.6.1;Standard Anti-Reflux Repairs;166
16.6.2;Lengthening Gastroplasties;167
16.6.3;Stricturoplasty and Intrathoracic Fundoplication;170
16.6.4;Vagotomy, Antrectomy, and Roux-en-Y Diversion;171
16.6.5;Treatment of the Short Esophagus by Minimally Invasive Surgery;171
16.7;Conclusion;171
16.8;References;172
17;14 Esophagectomy: Indications, Techniques, and Outcomes --- Mark K. Ferguson;174
17.1;History;174
17.2;Indications;175
17.2.1;Peptic Stricture;175
17.2.2;Gastrointestinal Bleeding;175
17.2.3;Multiple Failed Anti-Reflux Operations;176
17.2.4;Complications of Barrett’s Esophagus;176
17.3;Techniques;176
17.3.1;Patient Preparation;176
17.3.2;Approach;177
17.3.3;Extent of Resection;178
17.3.4;Procedure;179
17.4;Outcomes;182
17.5;Conclusions;183
17.6;References;183
18;15 Vagal Sparing Esophagectomy --- Steven R. DeMeester;186
18.1;Evaluation;187
18.2;Indications for Vagal-sparing Esophagectomy;187
18.3;Surgical Approach;188
18.4;Results;189
18.5;Summary;191
18.6;References;191
19;16 Future Directions of Therapy for GERD --- M. Brian Fennerty and Mark K. Ferguson;192
19.1;Physiologic Evaluation of Suspected GERD;192
19.2;Medical Therapy for GERD;192
19.3;Endoscopic Anti-Reflux Procedures;193
19.4;Newer Indications for Surgical Therapy;193
19.5;Centers of Surgical Excellence;194
19.6;Evaluation of the Failed Anti-Reflux Procedure;194
19.7;Endoscopic and Pharmacologic Therapy after a Failed Anti-Reflux Surgery;195
19.8;References;196
20;Index;198



Ihre Fragen, Wünsche oder Anmerkungen
Vorname*
Nachname*
Ihre E-Mail-Adresse*
Kundennr.
Ihre Nachricht*
Lediglich mit * gekennzeichnete Felder sind Pflichtfelder.
Wenn Sie die im Kontaktformular eingegebenen Daten durch Klick auf den nachfolgenden Button übersenden, erklären Sie sich damit einverstanden, dass wir Ihr Angaben für die Beantwortung Ihrer Anfrage verwenden. Selbstverständlich werden Ihre Daten vertraulich behandelt und nicht an Dritte weitergegeben. Sie können der Verwendung Ihrer Daten jederzeit widersprechen. Das Datenhandling bei Sack Fachmedien erklären wir Ihnen in unserer Datenschutzerklärung.